CoaguChek Vantus System
Test, Time, Prothrombin. 510(k) K170960, from Roche Diagnostics (Indianapolis, IN). Product code GJS, class 2.
As of Nov 19, 2026, K170960 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on Dec 25, 2017 after 269 days, with 1 recall tied to it in FDA's recall database.
- Review time: 269 days
- Recalls: 1
The CoaguChek® Vantus System measures an INR (International Normalized Ratio) based on a prothrombin time (PT) response to monitor the effect of a therapy with vitamin K antagonists by using the CoaguChek XS PT test strips. The CoaguChek Vantus System uses fresh capillary whole blood from a finger stick.
- Coaguchek XS SystemK062925 · Roche Diagnostics Corp. · Jan 29, 2007
| Started | Recall | Status |
|---|---|---|
| Sep 13, 2018 | Z-0360-2019Abnormally high INR test results with the affected CoaguChek test strips | Terminated |
- CoaguChek XS Plus SystemK253188 · Roche Diagnostics · Oct 24, 2025
- microINR SystemK251564 · Iline Microsystems, S.L. · Jul 21, 2025
- microINR SystemK243543 · Iline Microsystems, S.L. · Feb 27, 2025
- i-STAT PTplus Cartridge with the i-STAT 1 SystemK220282 · Abbott Laboratories · Jul 14, 2023
- microINR SystemK231711 · Iline Microsystems, S.L. · Jul 11, 2023
- STA- NeoPTimalK211485 · Diagnostica Stago S.A.S · Dec 23, 2022
- Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingK212779 · Coagusense, Inc. · Oct 5, 2022
- HemosIL ReadiPlasTinK213426 · Instrumentation Laboratory CO · Aug 16, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 31, 2017
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7750
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files